213 related articles for article (PubMed ID: 18483297)
1. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
Beltran AS; Sun X; Lizardi PM; Blancafort P
Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
[TBL] [Abstract][Full Text] [Related]
2. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).
Beltran AS; Blancafort P
Epigenetics; 2011 Feb; 6(2):224-35. PubMed ID: 20948306
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.
Ohike N; Maass N; Mundhenke C; Biallek M; Zhang M; Jonat W; Lüttges J; Morohoshi T; Klöppel G; Nagasaki K
Cancer Lett; 2003 Sep; 199(2):193-200. PubMed ID: 12969792
[TBL] [Abstract][Full Text] [Related]
6. Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.
Vijayaraghavalu S; Dermawan JK; Cheriyath V; Labhasetwar V
Mol Pharm; 2013 Jan; 10(1):337-52. PubMed ID: 23215027
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.
Primeau M; Gagnon J; Momparler RL
Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031
[TBL] [Abstract][Full Text] [Related]
8. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of tumor suppressor gene maspin in human bladder cancer.
Sugimoto S; Maass N; Takimoto Y; Sato K; Minei S; Zhang M; Hoshikawa Y; Jünemann KP; Jonat W; Nagasaki K
Cancer Lett; 2004 Jan; 203(2):209-15. PubMed ID: 14732229
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of maspin gene expression in human breast cancers.
Domann FE; Rice JC; Hendrix MJ; Futscher BW
Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
[TBL] [Abstract][Full Text] [Related]
11. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
[TBL] [Abstract][Full Text] [Related]
12. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
Zhang M; Maass N; Magit D; Sager R
Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
[TBL] [Abstract][Full Text] [Related]
13. HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.
Li X; Kaplun A; Lonardo F; Heath E; Sarkar FH; Irish J; Sakr W; Sheng S
Mol Cancer Res; 2011 Jun; 9(6):733-45. PubMed ID: 21622623
[TBL] [Abstract][Full Text] [Related]
14. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs.
Huisman C; van der Wijst MG; Falahi F; Overkamp J; Karsten G; Terpstra MM; Kok K; van der Zee AG; Schuuring E; Wisman GB; Rots MG
Epigenetics; 2015; 10(5):384-96. PubMed ID: 25830725
[TBL] [Abstract][Full Text] [Related]
15. Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene.
Zhang B; Huang T; Liu K; Chen J; Wang G
J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):543-6. PubMed ID: 18060631
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
17. Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.
Maass N; Hojo T; Zhang M; Sager R; Jonat W; Nagasaki K
Acta Oncol; 2000; 39(8):931-4. PubMed ID: 11206999
[TBL] [Abstract][Full Text] [Related]
18. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of maspin expression in the human placenta.
Dokras A; Coffin J; Field L; Frakes A; Lee H; Madan A; Nelson T; Ryu GY; Yoon JG; Madan A
Mol Hum Reprod; 2006 Oct; 12(10):611-7. PubMed ID: 16936308
[TBL] [Abstract][Full Text] [Related]
20. Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells.
Xu L; Liu H; Yu J; Wang Z; Zhu Q; Li Z; Zhong Q; Zhang S; Qu M; Lan Q
Oncol Rep; 2016 Jul; 36(1):57-64. PubMed ID: 27177016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]